WT

Whitehawk Therapeutics Inc

WHWK·NASDAQ

$4.40

+2.6%
HealthcareBiotechnology

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

At a Glance

Live Snapshot
Market Cap$217.59M
EPS-0.3300
P/E Ratio-13.33
Earnings Date08/06/2026

whwk

Effect of Foreign Exchange Changes on Cash

Last Annual Value

64.00K

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

%

WT

Whitehawk Therapeutics Inc Competitors Analysis of Effect of Foreign Exchange Changes on Cash

WHWK · NASDAQ
CompanyEffect of Foreign Exchange Changes on Cash
CAGR 3Y
CAGR 5Y
CAGR 10Y
64.00K
N/AN/AN/A 
-167.00K
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
-117.15M
N/AN/AN/A
-30.00K
N/AN/AN/A
231.00K
42.4%33.2%N/A
0.00
N/AN/AN/A
WT

Whitehawk Therapeutics Inc Fair Value Envelope

WHWK · NASDAQ

Our analysis suggests that WHWK has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.4, this represents a potential HIDDEN relative to our calculated worth for Whitehawk Therapeutics Inc.

Intrinsic Value
Current Price: $4.4